Evolus
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Evolus and other ETFs, options, and stocks.About EOLS
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau.
CEODavid Moatazedi
CEODavid Moatazedi
Employees332
Employees332
HeadquartersNewport Beach, California
HeadquartersNewport Beach, California
Founded2012
Founded2012
Employees332
Employees332
EOLS Key Statistics
Market cap330.58M
Market cap330.58M
Price-Earnings ratio-5.70
Price-Earnings ratio-5.70
Dividend yield—
Dividend yield—
Average volume1.93M
Average volume1.93M
High today$5.24
High today$5.24
Low today$4.95
Low today$4.95
Open price$5.09
Open price$5.09
Volume802.03K
Volume802.03K
52 Week high$17.12
52 Week high$17.12
52 Week low$4.74
52 Week low$4.74
Stock Snapshot
With a market cap of 330.58M, Evolus(EOLS) trades at $5.10. The stock has a price-to-earnings ratio of -5.70.
During the trading session on 2026-01-20, Evolus(EOLS) shares reached a daily high of $5.24 and a low of $4.95. At a current price of $5.10, the stock is +3.0% higher than the low and still -2.7% under the high.
Trading volume for Evolus(EOLS) stock has reached 802.03K, versus its average volume of 1.93M.
The stock's 52-week range extends from a low of $4.74 to a high of $17.12.
The stock's 52-week range extends from a low of $4.74 to a high of $17.12.
EOLS News
Simply Wall St 5d
Lacklustre Performance Is Driving Evolus, Inc.'s 30% Price DropEvolus, Inc. ( ) shares have had a horrible month, losing 30% after a relatively good period beforehand. The recent drop completes a disastrous twelve months fo...
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own EOLS. This list is generated using Robinhood data, and it’s not a recommendation.